Altimmune Inc (ALT)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
595,224,000
EV to revenue ratio (TTM)
10,653.24
EV to ebitda
11.93
Financial Performance
Revenue (TTM)
31,000
Gross profit (TTM)
-66,693,000
EBITDA
-98,634,000
Profitability
Operating margin (TTM)
-318,494.00%
Profit margin
0.00%
Return on assets (TTM)
-17.20%
Return on equity (TTM)
-28.90%
Per Share Metrics
Revenue per share (TTM)
0
EPS
-0.76
Diluted EPS (TTM)
-0.76
Book value
2.44
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
8.18
PEG ratio
32.62
Price to sales ratio (TTM)
19,200.78
Price to book ratio (TTM)
1.308
Growth
Quarterly earnings growth (YoY)
420.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
2
Buy
7
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.176